🇺🇸 FDA
Patent

US 8293764

Compositions and methods for disruption of BRCA2-Rad51 interaction

granted A61KA61K31/4725A61P

Quick answer

US patent 8293764 (Compositions and methods for disruption of BRCA2-Rad51 interaction) held by The Regents of the University of California expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4725, A61P, A61P15/00, A61P35/00